But now the environment for medical devices is turning positive, stated Das at the sidelines of the recently concluded Indian Pharma and India ... But the recommendation of the industry is that if and when it happens, then the entire value chain of diagnostics should be brought under the same ambit.
Read more: Capping of stent price irrelevant, when govt launched Ayushman Bharat: Experts